Lunai Bioworks (LNAI) Total Liabilities (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Total Liabilities of $19.4 million in Q1 2026, down 3.96% quarter-over-quarter from $20.2 million in Q4 2025, and down 33.83% on a YoY basis from $29.3 million in Q1 2025.
Lunai Bioworks (LNAI) Total Liabilities (2011 - 2026) Analysis & Trends
Lunai Bioworks' Total Liabilities history runs 16 years deep, the most recent figure standing at $19.4 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 33.83% year-over-year to $19.4 million; the TTM figure through Mar 2026 stood at $19.4 million (down 33.83% YoY), while the FY2025 annual figure was $29.6 million, down 5.04% from the prior year.
- Total Liabilities was $19.4 million for Q1 2026 at Lunai Bioworks, down from $20.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $43.7 million in Q1 2024 to a low of $10.8 million in Q3 2023.
- Historically, Total Liabilities has averaged $20.8 million across 5 years, with a median of $19.4 million in 2026.
- The sharpest annual moves came in 2024 and 2026: Total Liabilities jumped 246.63% in 2024, then sank 33.83% in 2026.
- A 5-year view of Total Liabilities shows it stood at $13.4 million in 2022, then grew by 7.84% to $14.4 million in 2023, then jumped by 103.02% to $29.3 million in 2024, then slumped by 30.96% to $20.2 million in 2025, then retreated by 3.96% to $19.4 million in 2026.
- The last three Total Liabilities figures came in at $19.4 million (Q1 2026), $20.2 million (Q4 2025), and $20.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 19.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.41 Mn |
| Dec 31, 2025 | 20.22 Mn |
| Sep 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 29.58 Mn |
| Mar 31, 2025 | 29.34 Mn |
| Dec 31, 2024 | 29.28 Mn |
| Sep 30, 2024 | 23.75 Mn |
| Jun 30, 2024 | 31.15 Mn |
| Mar 31, 2024 | 43.68 Mn |
| Dec 31, 2023 | 14.42 Mn |
| Sep 30, 2023 | 10.82 Mn |
| Jun 30, 2023 | 11.80 Mn |
| Mar 31, 2023 | 12.60 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Sep 30, 2022 | 12.75 Mn |
| Jun 30, 2022 | 12.01 Mn |
| Mar 31, 2022 | 18.86 Mn |
| Dec 31, 2021 | 17.52 Mn |
| Sep 30, 2021 | 17.09 Mn |
| Jun 30, 2021 | 14.94 Mn |